AbbVie Statistics

Total Valuation

AbbVie has a market cap or net worth of MXN 6.59 trillion. The enterprise value is 7.87 trillion.

Market Cap	6.59T
Enterprise Value	7.87T

Important Dates

The last earnings date was Friday, April 25, 2025.

Earnings Date	Apr 25, 2025
Ex-Dividend Date	Apr 15, 2025

Share Statistics

Current Share Class	1.77B
Shares Outstanding	n/a
Shares Change (YoY)	+0.03%
Shares Change (QoQ)	+0.17%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.77B

Valuation Ratios

The trailing PE ratio is 77.64 and the forward PE ratio is 15.03.

PE Ratio	77.64
Forward PE	15.03
PS Ratio	5.62
PB Ratio	220.65
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 14.46, with an EV/FCF ratio of 25.02.

EV / Earnings	92.64
EV / Sales	6.98
EV / EBITDA	14.46
EV / EBIT	21.07
EV / FCF	25.02

Financial Position

The company has a current ratio of 0.76, with a Debt / Equity ratio of 47.90.

Current Ratio	0.76
Quick Ratio	0.48
Debt / Equity	47.90
Debt / EBITDA	2.53
Debt / FCF	4.55
Interest Coverage	6.68

Financial Efficiency

Return on equity (ROE) is 88.40% and return on invested capital (ROIC) is 15.45%.

Return on Equity (ROE)	88.40%
Return on Assets (ROA)	8.34%
Return on Invested Capital (ROIC)	15.45%
Return on Capital Employed (ROCE)	19.06%
Revenue Per Employee	21.32M
Profits Per Employee	1.54M
Employee Count	55,000
Asset Turnover	0.40
Inventory Turnover	3.79

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +34.80% in the last 52 weeks. The beta is 0.54, so AbbVie's price volatility has been lower than the market average.

Beta (5Y)	0.54
52-Week Price Change	+34.80%
50-Day Moving Average	3,919.53
200-Day Moving Average	3,764.28
Relative Strength Index (RSI)	46.10
Average Volume (20 Days)	568

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.50

Income Statement

In the last 12 months, AbbVie had revenue of MXN 1.17 trillion and earned 84.92 billion in profits. Earnings per share was 47.83.

Revenue	1.17T
Gross Profit	832.66B
Operating Income	388.65B
Pretax Income	74.03B
Net Income	84.92B
EBITDA	559.33B
EBIT	388.65B
Earnings Per Share (EPS)	47.83

Full Income Statement

Balance Sheet

The company has 105.79 billion in cash and 1.43 trillion in debt, giving a net cash position of -1,325.42 billion.

Cash & Cash Equivalents	105.79B
Total Debt	1.43T
Net Cash	-1,325.42B
Net Cash Per Share	n/a
Equity (Book Value)	29.88B
Book Value Per Share	16.43
Working Capital	-178.39B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 335.22 billion and capital expenditures -20.77 billion, giving a free cash flow of 314.45 billion.

Operating Cash Flow	335.22B
Capital Expenditures	-20.77B
Free Cash Flow	314.45B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 71.01%, with operating and profit margins of 33.15% and 7.31%.

Gross Margin	71.01%
Operating Margin	33.15%
Pretax Margin	6.31%
Profit Margin	7.31%
EBITDA Margin	47.70%
EBIT Margin	33.15%
FCF Margin	26.82%

Dividends & Yields

This stock pays an annual dividend of 123.97, which amounts to a dividend yield of 3.31%.

Dividend Per Share	123.97
Dividend Yield	3.31%
Dividend Growth (YoY)	20.09%
Years of Dividend Growth	1
Payout Ratio	266.46%
Buyback Yield	-0.03%
Shareholder Yield	3.28%
Earnings Yield	1.29%
FCF Yield	4.77%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

AbbVie has an Altman Z-Score of 2.14. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.14
Piotroski F-Score	n/a